NCT00516633 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Hederos CA, Janson S, Andersson H, Hedlin G
Chest X-ray investigation in newly discovered asthma. Pediatr Allergy Immunol. 2004 Apr;15(2):163-5.
Hederos CA, Janson S, Hedlin G
Group discussions with parents have long-term positive effects on the management of asthma with good cost-benefit. Acta Paediatr. 2005 May;94(5):602-8.
Hederos CA
Neuropsychologic changes and inhaled corticosteroids. J Allergy Clin Immunol. 2004 Aug;114(2):451-2.

Does Improved Information in the Form of Group Discussions With Parents of Newly Diagnosed Asth-Matic Children Lead to a Better Quality of Life for the Families, an Improved Adherence and Better Devel-Opment of the Lung Function of the Children?

Details for clinical trial NCT00516633

Clinical trial NCT00516633 - References